VARELISA B2 GLYCOPROTEIN I IGM ANTIBODIES, MODELS 18848 AND 18896— 510(k) K040451

Name: FDA 510(k) clearance K040451
Creator: U.S. Food and Drug Administration
Published: 2004-05-11

Substantially Equivalent

Pharmacia Deutschland GmbH

FDA 510(k) clearance K040451 for VARELISA B2 GLYCOPROTEIN I IGM ANTIBODIES, MODELS 18848 AND 18896, Substantially Equivalent on 2004-05-11. Applicant: Pharmacia Deutschland GmbH. Device class: 2.

Clearance details

Applicant: Pharmacia Deutschland GmbH
Product code: Code MSV
Device class: Class 2
Regulation: 21 CFR 866.5660
Advisory panel: Immunology
Date received: 2004-02-20
Decision date: 2004-05-11
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Freiburg, DE

Download summary PDF View on FDA.gov ↗

Recent devices under product code MSV

view all

K243979 — Aptiva APS IgA Reagent2026-02-06
K181329 — EliA B2-Glycoprotein I IgA Immunoassay, EliA Cardiolipin IgA Immunoassay2018-06-25
K162788 — ImmuLisa Enhanced B2GP1 IgA Antibody ELISA, ImmuLisa Enhanced B2GP1 IgG Antibody ELISA, ImmuLisa Enhanced B2GP1 IgM Antibody ELISA, ImmuLisa Enhanced B2GP1 IgA/IgG/IgM Antibody ELISA2017-06-19
K152875 — QUANTA Flash B2GP1-Domain1, QUANTA Flash B2GP1-Domain1 Controls, HemosIL AcuStar Anti-B2GPI Domain 1, HemosIL AcuStar Anti-B2GPI Domain 1 Controls2015-12-21
K141274 — QUANTA FLASH ¿2GP1-DOMAIN1; CONTROLS, HEMOSIL ACUSTAR ANTI-¿2GPI DOMAIN1; CONTROLS.2015-02-13

More clearances from Pharmacia Deutschland GmbH

view all

K041043 — VARELISA PR3 ANCA, MODEL NUMBER 17748/177962004-07-02
K040810 — VARELISA HISTONE ANTIBODIES, MODEL 164962004-05-14
K040811 — VARELISA SSDNA ANTIBODIES, MODEL 148962004-05-13
K040449 — VARELISA B2 GLYCOPROTEIN I IGG ANTIBODIES, MODELS 18748 AND 187962004-05-11
K040450 — VARELISA B2 GLYCOPROTEIN I IGA ANTIBODIES, MODELS 18948 AND 189962004-05-11

Data sourced from openFDA. This site is unofficial and independent of the FDA.